SI-BONE, Inc. (SIBN): Capital Expenditures

Annual figures by period end, from SEC filings.

$8.41M
Year ended 2025-12-31
$6.87M
Trailing 12 months to 2026-06-30
-4.0%
3-year compound annual growth
+26.9%
5-year compound annual growth
$10.50M2017-12-31: $478.0K2018-12-31: $942.0K2019-12-31: $2.44M2020-12-31: $2.56M2021-12-31: $6.39M2022-12-31: $9.51M2023-12-31: $7.80M2024-12-31: $10.50M2025-12-31: $8.41M$8.41M
2017-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$8.41M-19.8%2026-02-24, From 2025-01-01
2024-12-31$10.50M+34.6%2026-02-24, From 2024-01-01
2023-12-31$7.80M-18.0%2026-02-24, From 2023-01-01
2022-12-31$9.51M+48.8%2025-02-25, From 2022-01-01
2021-12-31$6.39M+149.5%2023-03-02, From 2021-01-01
2020-12-31$2.56M+4.7%2022-03-01, From 2020-01-01
2019-12-31$2.44M+159.6%2021-03-10, From 2019-01-01
2018-12-31$942.0K+97.1%2020-03-11, From 2018-01-01
2017-12-31$478.0Kn/a2019-03-14, From 2017-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
SI-BONE, Inc. (SIBN)2025-12-31$8.41M-19.8%
Treace Medical Concepts, Inc. (TMCI)2025-12-31$13.52M+16.6%
Heartflow, Inc. (HTFL)2025-12-31$5.03M+15.3%
Cerus Corp (CERS)2025-12-31$3.73M+31.4%
Orthopediatrics Corp (KIDS)2025-12-31$11.11M-22.1%
Lemaitre Vascular Inc (LMAT)2025-12-31$6.78M-2.6%
Neuronetics, Inc. (STIM)2025-12-31$801.0K-45.4%
InfuSystem Holdings, Inc (INFU)2025-12-31$560.0K-48.7%
SkinHealth Systems Inc. (SKIN)2025-12-31$303.0K-59.9%

Compare SIBN, TMCI, HTFL, CERS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗